Birdwatch Note Rating
2023-03-17 00:39:07 UTC - HELPFUL
Rated by Participant: 9273FB978B169F4C5DA9F045CAD35479254A11AA0A806F86CE60F88E43B433BA
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details